B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab

•Rituximab is an effective treatment for multiple sclerosis patients.•During follow-up, a substantial increase of BL counts was preceded by initial values of 0.2–0.3%.•Rituximab retreatment guided by this cut-off BL showed high effectiveness in MS patients.•This approach may reduce adverse such as i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis and related disorders 2022-12, Vol.68, p.104218-104218, Article 104218
Hauptverfasser:	Chico-García, Juan Luis, Rodríguez-Jorge, Fernando, Sainz-Amo, Raquel, Monreal, Enric, Walo-Delgado, Paulette, Roldán, Ernesto, Rodríguez-Martín, Eulalia, Masjuan, Jaime, Costa-Frossard, Lucienne, Sainz de la Maza, Susana, Villar, Luisa Maria
Format:	Artikel
Sprache:	eng
Schlagworte:	B-Lymphocytes Female Flow cytometry analyses Humans Immunologic Factors - adverse effects Male Middle Aged Multiple sclerosis Multiple Sclerosis - chemically induced Multiple Sclerosis, Relapsing-Remitting - chemically induced Prospective Studies Rituximab Rituximab - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!